Monshat Kaveh, Carty Bridget, Olver James, Castle David, Bosanac Peter
Department of Psychiatry, University of Melbourne, St Vincent's Hospital, Fitzroy, VIC, Australia.
Australas Psychiatry. 2010 Jun;18(3):238-41. doi: 10.3109/10398561003681327.
Availability of new psychotropic agents, and formulations, as well as expanded indications for previously available agents, has had an impact on prescribing patterns in community psychiatric practice. This study tracked changes in patient diagnostic profiles and compared antipsychotic prescribing patterns for patients managed by a continuing care team over a 2.25-year period.
Data pertaining to patient diagnoses and psychotropic medications was obtained from sequential cross-sectional file review and the pharmacy database. Data were collected in late 2004 (n = 224) and early 2007 (n = 294).
The majority of patients suffered from DSM-IV schizophrenia, schizoaffective and related disorders (68% in 2004, 71% in 2007). Second generation antipsychotic (SGA) medications (79% in 2004, 99% in 2007 of all antipsychotics) were the most widely used agents. Use of quetiapine as a proportion of all oral SGAs increased (8% to 17%) as did that of long-acting risperidone (<1% to 17% of all antipsychotics) paralleled by a decline in long-acting first generation antipsychotic agents (15% to <1%). Significant changes in the prescription of non-benzodiazepine hypnotics and mood stabilizers were also noted.
Statistically significant changes in prescribing patterns of antipsychotics during the study period were noted. Likely causes are discussed.
新型精神药物及其剂型的出现,以及现有药物适应证的扩大,对社区精神病学实践中的处方模式产生了影响。本研究追踪了患者诊断概况的变化,并比较了连续护理团队在2.25年期间管理的患者的抗精神病药物处方模式。
从连续的横断面档案审查和药房数据库中获取有关患者诊断和精神药物的数据。数据收集于2004年末(n = 224)和2007年初(n = 294)。
大多数患者患有DSM-IV精神分裂症、分裂情感性障碍及相关疾病(2004年为68%,2007年为71%)。第二代抗精神病药物(SGA)(在所有抗精神病药物中,2004年占79%,2007年占99%)是使用最广泛的药物。喹硫平在所有口服SGA中的使用比例增加(从8%增至17%),长效利培酮的使用比例也增加(从所有抗精神病药物的<1%增至17%),与此同时,长效第一代抗精神病药物的使用比例下降(从15%降至<1%)。非苯二氮䓬类催眠药和心境稳定剂的处方也有显著变化。
研究期间抗精神病药物的处方模式发生了具有统计学意义的变化。讨论了可能的原因。